<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04041700</url>
  </required_header>
  <id_info>
    <org_study_id>CBAS5751</org_study_id>
    <nct_id>NCT04041700</nct_id>
  </id_info>
  <brief_title>Clinical Performance, Safety and Patient Reported Outcomes of an Active Osseointegrated Steady-State Implant System</brief_title>
  <official_title>A Prospective, Multicentre, Open Clinical Investigation Evaluating Clinical Performance, Safety and Patient Reported Outcomes With an Active Osseointegrated Steady-State Implant System (OSI) in Adult Subjects With Conductive Hearing Loss, Mixed Hearing Loss or Single-sided Sensorineural Deafness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cochlear</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Statistiska konsultgruppen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cochlear</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this clinical investigation is to collect data on objective and subjective hearing
      performance, quality of life and safety in adult subjects with conductive hearing loss, mixed
      hearing loss or single-sided sensorineural deafness.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 27, 2019</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in hearing performance with the Osia 2 system at 3 months post-surgery compared to preoperative unaided condition assessed via audiometric thresholds</measure>
    <time_frame>Baseline before surgery, 3 months after surgery</time_frame>
    <description>Free field (Pure Tone Average 4, mean of 0.5, 1,2 and 4 kHz)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in hearing performance with the Osia 2 system at 3 months post-surgery compared to preoperative unaided situation assessed via adaptive speech recognition in noise</measure>
    <time_frame>Baseline before surgery, 3 months after surgery</time_frame>
    <description>Speech-to-noise ratio, 50% speech understanding</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in hearing performance with the Osia 2 system at 4 weeks and 6 months post surgery compared to preoperative unaided situation assessed via audiometric thresholds</measure>
    <time_frame>Baseline before surgery, 4 weeks and 6 months after surgery</time_frame>
    <description>Free field (Pure Tone Average 4, mean of 0.5, 1,2 and 4 kHz)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hearing performance with the Osia 2 system at 4 weeks and 6 months post surgery compared to preoperative unaided situation assessed via adaptive speech recognition in noise</measure>
    <time_frame>Baseline before surgery, 4 weeks and 6 months after surgery</time_frame>
    <description>Speech-to-noise ratio, 50% speech understanding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hearing performance with the Osia 2 system at 4 weeks, 3 months and 6 months post surgery compared to preoperative unaided situation assessed via audiometric thresholds</measure>
    <time_frame>Baseline before surgery, 4 weeks, 3 months and 6 months after surgery</time_frame>
    <description>Free-field [0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0 and 8.0 kHz]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hearing performance with the Osia 2 system at 4 weeks, 3 months and 6 months post surgery compared to preoperative unaided situation assessed via speech recognition in quiet</measure>
    <time_frame>Baseline before surgery, 4 weeks, 3 months and 6 months after surgery</time_frame>
    <description>% correctly perceived words at 50dB, 65dB and 80dB SPL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Benefit in self-reported hearing outcome with the Osia 2 system at 3 months and 6 months post surgery compared to the preoperative unaided situation via Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaire</measure>
    <time_frame>Baseline before surgery, 3 months and 6 months after surgery</time_frame>
    <description>Measuring change of Ease of communication, Reverberation, Background noise, Aversiveness and a Global score with the Osia 2 System from the pre-operative unaided situation. The absolute APHAB scale is between 0 and 100%, where 0% indicates no problems and 100% indicates always problem. The change from unaided to aided hearing is presented. A positive value indicates an improvement, a negative value an impairment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Benefit in self-reported hearing outcome with the Osia 2 system at 3 months and 6 months post surgery compared to the preoperative unaided situation via the Speech, Spatial and Qualities of Hearing Scale (SSQ) questionnaire</measure>
    <time_frame>Baseline before surgery, 3 months and 6 months after surgery</time_frame>
    <description>Measuring change of speech, spatial and hearing experiences with the Osia 2 System from the pe-operative unaided situation. A scale from 0 to 10 is used, where 0 represents &quot;can not hear at all&quot;, and 10 &quot;hear perfectly&quot;. The change from unaided to aided hearing is presented. A positive value indicates improved hearing, a negative value indicates impaired hearing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Benefit in health-related quality of life with the Osia 2 system at 3 months and 6 months post surgery compared to the preoperative unaided situation via the Health Utilities Index Mark III (HUI) questionnaire</measure>
    <time_frame>Baseline before surgery, 3 months and 6 months after surgery</time_frame>
    <description>Change of health status and health related quality of life using the generic quality of life scale Health Utilities Index (HUI3) when wearing Osia 2 System compared to the pre-operative unaided situation. A health utility value of 1.00 indicates perfect health while a score of 0.00 indicates death. The change from unaided to aided hearing is presented. A positive value indicates an improved quality of life, a negative value indicates impaired quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical information: soft tissue thickness</measure>
    <time_frame>Baseline before surgery or at surgery</time_frame>
    <description>Measured in mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical information: surgery time</measure>
    <time_frame>At surgery</time_frame>
    <description>Time in minutes between first incision to last suture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical information: bone polishing/removal at the actuator site</measure>
    <time_frame>At surgery</time_frame>
    <description>Yes/No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical information: BI300 Implant length</measure>
    <time_frame>At surgery</time_frame>
    <description>3 mm/4 mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical information: location of BI300 Implant</measure>
    <time_frame>At surgery</time_frame>
    <description>Measured in mm between the ear canal and the center of the actuator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical information: type of anesthesia</measure>
    <time_frame>At surgery</time_frame>
    <description>General/local</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical information: soft tissue reduction</measure>
    <time_frame>At surgery</time_frame>
    <description>Yes/No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical information: surgical incision type</measure>
    <time_frame>At surgery</time_frame>
    <description>Examples: C-shaped/S-shaped/straight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical information: location of the surgical incision in relation to the actuator</measure>
    <time_frame>At surgery</time_frame>
    <description>Anterior/posterior</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical information: estimated length of the surgical incision</measure>
    <time_frame>At surgery</time_frame>
    <description>Measured in mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical information: placement of the coil</measure>
    <time_frame>At surgery</time_frame>
    <description>Periosteal pocket (under periosteal)/on top of periosteum/on top of muscle)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability information: magnet choice</measure>
    <time_frame>At 4 weeks, 6 weeks, 3 months and 6 months after surgery</time_frame>
    <description>Magnet strength ranging from 1 to 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability information: Sound Processor retention</measure>
    <time_frame>At 4 weeks, 6 weeks, 3 months and 6 months after surgery</time_frame>
    <description>Assessed via a Visual Analog Scale 100mm with insufficient retention to the left and excellent retention to the right</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability information: Sound Processor wearing comfort</measure>
    <time_frame>At 4 weeks, 6 weeks, 3 months and 6 months after surgery</time_frame>
    <description>Assessed via a Visual Analog Scale 100mm with no comfort at all to the left and excellent comfort to the right</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability information: use of SoftWear pad</measure>
    <time_frame>At 4 weeks, 6 weeks, 3 months and 6 months after surgery</time_frame>
    <description>Yes/No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability information: daily use of sound processor</measure>
    <time_frame>At 4 weeks, 6 weeks, 3 months and 6 months after surgery</time_frame>
    <description>Average hours of daily use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability information: daily streaming time of sound processor</measure>
    <time_frame>At 4 weeks, 6 weeks, 3 months and 6 months after surgery</time_frame>
    <description>Average hours of daily streaming</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability information: battery lifetime of sound processor</measure>
    <time_frame>At 4 weeks, 6 weeks, 3 months and 6 months after surgery</time_frame>
    <description>Average hours of battery lifetime</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in hearing performance between the Osia 2 system and a Baha 5 Power Sound Processor on a Baha Softband (preoperative) at 4 weeks, 3 months and 6 months post surgery assessed via audiometric thresholds</measure>
    <time_frame>Baseline before surgery, 4 weeks, 3 months and 6 months after surgery</time_frame>
    <description>Free-field [Pure Tone Average 4, Mean of 0.5, 1, 2 and 4 kHz].</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in hearing performance between the Osia 2 system and a Baha 5 Power Sound Processor on a Baha Softband (preoperative) at 4 weeks, 3 months and 6 months post surgery assessed via audiometric thresholds</measure>
    <time_frame>Baseline before surgery, 4 weeks, 3 months and 6 months after surgery</time_frame>
    <description>Free-field [0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0 and 8.0 kHz].</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in hearing performance between the Osia 2 system and a Baha 5 Power Sound Processor on a Baha Softband (preoperative) at 4 weeks, 3 months and 6 months post surgery assessed via adaptive speech recognition in noise</measure>
    <time_frame>Baseline before surgery, 4 weeks, 3 months and 6 months after surgery</time_frame>
    <description>Signal-to-noise ratio, 50% speech understanding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in hearing performance between the Osia 2 system and a Baha 5 Power Sound Processor on a Baha Softband (preoperative) at 4 weeks, 3 months and 6 months post surgery assessed via speech recognition in quiet</measure>
    <time_frame>Baseline before surgery, 4 weeks, 3 months and 6 months after surgery</time_frame>
    <description>% correctly perceived words at 50dB, 65dB and 80dB SPL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in hearing performance between the Osia 2 system and a Baha 5 Power Sound Processor on a Baha Softband (preoperative) at 4 weeks, 3 months and 6 months post surgery assessed via Bone Conduction (BC) direct</measure>
    <time_frame>Baseline before surgery, 4 weeks, 3 months and 6 months after surgery</time_frame>
    <description>BC direct (0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0 and 6.0 kHz)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hearing Loss</condition>
  <arm_group>
    <arm_group_label>Osia 2 system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Osia 2 system</intervention_name>
    <description>System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound processor.</description>
    <arm_group_label>Osia 2 system</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject with conductive hearing loss or mixed hearing loss in the ear to be implanted.
             Bone conduction thresholds with pure tone average (PTA4; mean of 0.5, 1, 2 and 4 kHz)
             of ≤ 55 dB sensorineural hearing loss.

        OR Subject with single-sided sensorineural deafness who is a candidate for Baha surgery.
        Air conduction thresholds with a pure tone average PTA4 (mean of 0.5, 1, 2 and 3 kHz) of ≤
        20 dB sensorineural hearing loss in the good ear OR subject who is indicated for an (Air
        Conduction-Contralateral Routing of Signal (AC CROS) but—for some reason—cannot or will not
        use an AC CROS.

          -  Adult subjects (18 years or older).

          -  Previous experience from amplified sound through properly fitted amplification (for
             example but not limited to Hearing aid, Contralateral Routing of Signal (CROS) device,
             Bone conduction hearing device on softband).

          -  Candidate is a fluent speaker in the language used to assess speech perception
             performance.

          -  Willing and able to provide written informed consent

        Exclusion Criteria:

          -  Uncontrolled diabetes as judged by the investigator.

          -  Condition that could jeopardise osseointegration and/or wound healing (e.g.
             osteoporosis, psoriasis, long-term systemic use of corticosteroids) or condition that
             may have an impact on the outcome of the investigation as judged by the investigator.

          -  Insufficient bone quality and quantity to support successful implant placement.

          -  Previous surgery and/or implantation with any bone conduction/active device on the
             side to be implanted, which may jeopardise the implantation and use of the Osia 2
             system, as judged by the investigator.

          -  Use of ototoxic drugs that could be harmful to the hearing, as judged by the
             investigator.

          -  Unable to follow investigational procedures, e.g. to complete quality of life scales,
             or unwilling to comply with the requirements of the clinical investigation as
             determined by the investigator.

          -  Condition with a likely negative progression and/or with expected relapses
             jeopardising general wellbeing and health-related quality of life as judged by the
             investigator.

          -  Subject that has received radiotherapy in the area of implantation or is planned for
             such radiotherapy during the study period.

          -  Investigator site personnel directly affiliated with this study and/or their immediate
             families; immediate family is defined as a spouse, parent, child, or sibling.

          -  Cochlear employees or employees of Contract Research Organisations or contractors
             engaged by Cochlear for the purposes of this investigation

          -  Currently participating, or participated within the last 30 days, in another
             interventional clinical investigation involving an investigational drug or device.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stina Wigren</last_name>
    <role>Study Director</role>
    <affiliation>Cochlear</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna Östblom</last_name>
    <phone>+46317924575</phone>
    <email>aostblom@cochlear.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Johan Blechert</last_name>
    <email>jblechert@cochlear.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sydney Cochlear Implant Centre</name>
      <address>
        <city>Gladesville</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Birman, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Royal Victorian Eye and Ear Hospital</name>
      <address>
        <city>Melbourne</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Briggs, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Otorhinolaryngology, Head and Neck Surgery Faculty of Medicine. The Chinese University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Tong, Prof.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>July 30, 2019</study_first_submitted>
  <study_first_submitted_qc>July 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2019</study_first_posted>
  <last_update_submitted>January 31, 2020</last_update_submitted>
  <last_update_submitted_qc>January 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hearing Loss, Conductive</keyword>
  <keyword>Hearing Loss, Mixed</keyword>
  <keyword>Deafness, sensorineural single-sided</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

